Martin Rothschild, MD
NPI 1023195401ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· New York, NY
Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in New York, New York, trained at New York Medical College (class of 1973). Their prescriptions cost Medicare Part D more than their services did: $356,508 for 1,040 claims, against $30,823 paid for services in 2024. Abbvie Inc. was the largest of 5 companies reporting payments in 2025, $383.42 in all, mostly food and beverage.
Overview
| NPI | 1023195401 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Nov 1, 2006 |
| Last updated in NPPES | Nov 23, 2010 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | 121050 | NY |
| Internal Medicine | 207R00000X | NYS121050 | NY |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Endocrinology (NY) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 67 |
|---|---|
| Services billed | 12,750 across 11 procedure codes |
| Paid by Medicare | $30,823 |
Part D prescriptions in 2024
| Prescriptions (claims) | 1,040 · 2,634 30-day fills |
|---|---|
| Patients | 72 |
| Total drug cost | $356,508 |
| Generic share | 67% of claims |
Education and affiliations
| Medical school | New York Medical College |
|---|---|
| Graduation year | 1973 |
| Medicare specialty | Endocrinology |
| Secondary specialties | Internal Medicine |
Industry payments (Open Payments)
- 2025$383.42 · 30 payments from 5 companies
- 2024$606.31 · 41 payments from 6 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Abbvie Inc. | $148.12 | 19 |
| Bayer Healthcare Pharmaceuticals Inc. | $123.52 | 6 |
| Lilly USA, LLC | $79.12 | 3 |
| Novo Nordisk Inc | $18.23 | 1 |
| Astrazeneca Pharmaceuticals LP | $14.43 | 1 |
What the 2025 payments were for
- Food and Beverage$363.80 · 29 payments
- Education$19.62 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in New York
- 1346562345
- 1285938381
- 1093087926
- 1417145145
- 1710128053
- 1134500762
- 1689271629
- 1841956638
- 1639895055
- 1205076890
- 1649456286
- 1396153920
All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in New York →